Snapshot from Jul 19, 2026 at 14:14 UTC. For live data and tracking: View Live
Events / Business / MindMaze Therapeutics AGM Results
Business Annual General Meeting

MindMaze Therapeutics AGM Results

Analysis based on 7 articles · First reported Jun 25, 2026 · Last updated Jun 25, 2026

Sentiment
10
Attention
2
Articles
7
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The market impact for Coeptis Therapeutics Holdings is mildly positive due to the approval of most proposals and the election of new board members, suggesting stable governance. However, the rejection of the conditional share capital increase could be seen as a slight negative, potentially limiting the company's future financial flexibility for growth or acquisitions.

Biotechnology Healthcare
Event Summary

Coeptis Therapeutics Holdings held its Annual General Meeting on June 25, 2026. Shareholders approved most proposals from the Board of Directors, including the 2025 Annual Report, financial statements, and compensation proposals. Walid Hanna, Olaf Blanke, and Martin Reiss were re-elected to the Board, and Brad Hollinger (Founder, Chairman, and CEO of Vibra Healthcare) and Rose Henderson (CEO of Coeptis Therapeutics Holdings) were elected as new board members. Walid Hanna was also re-elected as Chairman. A key proposal to increase conditional share capital, however, did not receive the required qualified majority and was therefore not approved.

Entities Involved
stock
Coeptis Therapeutics Holdings
Coeptis Therapeutics Holdings held its Annual General Meeting where shareholders approved most proposals, re-elected and elected new board members, and approved financial statements. However, a proposal to increase conditional share capital was not approved, which could limit future fundraising flexibility.
Importance 100.0 Sentiment 10.0
per
Walid Hanna
Walid Hanna was re-elected to the Board of Directors and re-elected as Chairman of the Board of Directors for Coeptis Therapeutics Holdings, indicating continued leadership in the company.
Importance 70.0 Sentiment 10.0
per
Brad Hollinger
Brad Hollinger was elected as a new member of the Board of Directors for Coeptis Therapeutics Holdings, bringing his experience as Founder, Chairman and CEO of Vibra Healthcare.
Importance 60.0 Sentiment 10.0
per
Rose Henderson
Rose Henderson, the Chief Executive Officer of Coeptis Therapeutics Holdings, was elected as a new member of the Board of Directors, strengthening his leadership role within the company.
Importance 60.0 Sentiment 10.0
per
Olaf Blanke
Olaf Blanke was re-elected to the Board of Directors of Coeptis Therapeutics Holdings.
Importance 30.0 Sentiment 0.0
per
Martin Reiss
Martin Reiss was re-elected to the Board of Directors of Coeptis Therapeutics Holdings.
Importance 30.0 Sentiment 0.0
priv
Vibra Healthcare
Vibra Healthcare is mentioned as the company where Brad Hollinger serves as Founder, Chairman, and CEO, and his election to the board of Coeptis Therapeutics Holdings could potentially foster future collaborations or strategic insights.
Importance 20.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.